Results 281 to 290 of about 5,297,540 (313)

Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial.

Annals of Oncology
BACKGROUND The standard of care for the treatment of locally advanced rectal cancer results in an excellent local disease control but the metastasis rates remain high.
T. Conroy, F. Castan, P. Etienne, E. Rio, N. Mesgouez-Nebout, L. Evesque, V. Vendrely, X. Artignan, O. Bouché, D. Gargot, V. Boige, N. Bonichon-Lamichhane, C. Louvet, C. Morand, C. de la Fouchardière, A. Boilève, M. Delaye, S. Gourgou, V. Pezzella, C. Borg   +19 more
semanticscholar   +1 more source

Neoadjuvant Therapy for Resectable Pancreatic Cancer

Annals of Surgery, 2021
Supplemental Digital Content is available in the text Objective: The aim of this study was to pool data from randomized controlled trials (RCT) limited to resectable pancreatic ductal adenocarcinoma (PDAC) to determine whether a neoadjuvant therapy ...
D. L. Birrer, H. Golcher, R. Casadei, S. Haile, R. Fritsch, S. Hussung, T. Brunner, R. Fietkau, T. Meyer, R. Grützmann, S. Merkel, C. Ricci, C. Ingaldi, M. Di Marco, A. Guido, C. Serra, F. Minni, B. Pestalozzi, H. Petrowsky, M. DeOliveira, W. Bechstein, C. Bruns, C. Oberkofler, M. Puhan, M. Lesurtel, S. Heinrich, P. Clavien   +26 more
semanticscholar   +1 more source

Total Neoadjuvant Therapy in Rectal Cancer: A Systematic Review and Meta-analysis of Treatment Outcomes.

Annals of Surgery, 2020
BACKGROUND The addition of induction chemotherapy to concomitant neoadjuvant chemoradiation in locally advanced rectal cancer could increase pathological downstaging and act on occult micrometastatic disease, leading ultimately to a better outcome.
F. Petrelli, F. Trevisan, M. Cabiddu, G. Sgroi, L. Bruschieri, E. Rausa, M. Ghidini, L. Turati   +7 more
semanticscholar   +1 more source

Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12.

Journal of Clinical Oncology, 2019
PURPOSE Total neoadjuvant therapy is a new paradigm for rectal cancer treatment. Optimal scheduling of preoperative chemoradiotherapy (CRT) and chemotherapy remains to be established.
E. Fokas, M. Allgäuer, B. Polat, G. Klautke, G. Grabenbauer, R. Fietkau, T. Kuhnt, L. Staib, T. Brunner, A. Grosu, W. Schmiegel, L. Jacobasch, J. Weitz, G. Folprecht, A. Schlenska-Lange, M. Flentje, C. Germer, R. Grützmann, M. Schwarzbach, V. Paolucci, W. Bechstein, T. Friede, M. Ghadimi, R. Hofheinz, C. Rödel   +24 more
semanticscholar   +1 more source

Importance of Normalization of CA19-9 Levels Following Neoadjuvant Therapy in Patients With Localized Pancreatic Cancer.

Annals of Surgery, 2020
OBJECTIVE Carbohydrate antigen 19-9 (CA19-9) is a prognostic marker for patients with pancreatic cancer (PC), but its value as a treatment biomarker is unclear.
S. Tsai, B. George, D. Wittmann, P. Ritch, A. Krepline, M. Aldakkak, C. Barnes, K. Christians, K. Dua, Michael O. Griffin, Catherine E Hagen, W. Hall, B. Erickson, Douglas B. Evans   +13 more
semanticscholar   +1 more source

Neoadjuvant therapy for pancreatic cancer

Nature Reviews Clinical Oncology, 2023
C. Springfeld, C. Ferrone, M. Katz, P. Philip, T. Hong, T. Hackert, M. Büchler, J. Neoptolemos   +7 more
semanticscholar   +1 more source

Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)

Nature Medicine, 2021
A. Menzies, R. Amaria, E. Rozeman, Alexander C. Huang, M. Tetzlaff, B. A. Van de Wiel, S. Lo, A. Tarhini, E. Burton, T. Pennington, R. Saw, Xiaowei Xu, G. Karakousis, P. Ascierto, A. Spillane, A. V. Van Akkooi, M. Davies, T. Mitchell, H. Tawbi, R. Scolyer, J. Wargo, C. Blank, G. Long   +22 more
semanticscholar   +1 more source

Surgical resection rates after neoadjuvant therapy for localized pancreatic ductal adenocarcinoma: meta-analysis.

British Journal of Surgery, 2022
Zachary J. Brown, Victor K. Heh, H. Labiner, G. Brock, A. Ejaz, M. Dillhoff, A. Tsung, T. Pawlik, J. Cloyd   +8 more
semanticscholar   +1 more source

Multimodal Prehabilitation During Neoadjuvant Therapy Prior to Esophagogastric Cancer Resection: Effect on Cardiopulmonary Exercise Test Performance, Muscle Mass and Quality of Life—A Pilot Randomized Clinical Trial

Annals of Surgical Oncology, 2021
S. Allen, V. Brown, D. White, D. King, J. Hunt, J. Wainwright, A. Emery, Emily Hodge, Aga Kehinde, P. Prabhu, T. Rockall, S. Preston, J. Sultan   +12 more
semanticscholar   +1 more source

Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy.

The Lancet Oncology, 2018
C. Denkert, G. von Minckwitz, S. Darb-Esfahani, B. Lederer, B. Heppner, K. Weber, J. Budczies, J. Huober, F. Klauschen, J. Furlanetto, W. Schmitt, J. Blohmer, T. Karn, B. Pfitzner, S. Kümmel, K. Engels, A. Schneeweiss, A. Hartmann, A. Noske, P. Fasching, C. Jackisch, M. V. van Mackelenbergh, P. Sinn, C. Schem, C. Hanusch, M. Untch, S. Loibl   +26 more
semanticscholar   +1 more source